Aspirin (BLOOD THINNER)
A 1986 in vitro and ex vivo research published in the Arzneimittelforschung journal revealed that curcumin has anti-platelet and prostacyclin balancing impacts contrasted with aspirin, showing it may be beneficial to patients inclined to vascular thrombosis, and in need of anti-arthritis therapy.
ANTI-INFLAMMATORY DRUGS
A 2004 research published in the Oncogene journal revealed that curcumin (and resveratrol) were viable options to the medications aspirin, ibuprofen, sulindac, phenylbutazone, naproxen, indomethacin, diclofenac, dexamethasone, celecoxib, and tamoxifen in pushing calming and anti-proliferative actions against tumor cells.
OXALIPLATIN (CHEMOTHERAPY DRUG)
A 2007 research published in the International Journal of Cancer revealed that curcumin contrasts positively and oxaliplatin, as an antiproliferative agenet in colorectal cell lines.
METFORMIN (DIABETES DRUG)
A 2009 research published in the Biochemistry and Biophysical Research Community journal investigated how curcumin may be beneficial in treating diabetes, observing that it initiates AMPK (which expands glucose uptake) and suppresses gluconeogenic gene expression (which suppresses formulation of glucose in the liver) in hepatoma cells.
Fascinatingly, they discovered curcumin to be 500 times to 100,000 times (in the structure known as tetrahydrocurcuminoids(thc)) stronger than metformin in triggering AMPK and its downstream target acetyl-Coa carboxylase (ACC).
An alternative way in which turmeric and its segments uncover their noteworthy curative properties is in exploration of drug resistant- and multi-drug resistant tumors.
We have two categories on our site devoted to exploring natural and integrative treatments on these subjects, keeping in mind there are many substances with evident viability against these chemotherapy- and radiation-safe tumors, curcumin tops both records:
Tumors: Drug Resistant
Tumors: Multi-Drug Resistant
We have discovered more than 54 researches demonstrating that curcumin can incite cell death ensitize drug-resistant tumor cell lines to ordinary treatment.
We have distinguished 27 studies on curcumins capability to either cause cell death or sensitize multi-drug resistant tumor cells to ordinary treatment.
Considering the turmerics solid track record, used as both food and medicine in different cultures, for a huge number of years, a solid argument can be made for using curcumin as a medication or adjuvant in tumor treatment.
On the other hand, believe it or not, you can use confirmed natural (non-irradiated) turmeric in lower culinary measurements regularly, with the goal that courageous dosages wont be fundamental later on, after the arrival of a serious illness. Feeding yourself, as opposed to curing yourself with nutraceuticals, ought to be the objective of a healthy eating regimen.
Source:
www.naturalcuresnotmedicine.com
References:
www.greenmedinfo.com
A 1986 in vitro and ex vivo research published in the Arzneimittelforschung journal revealed that curcumin has anti-platelet and prostacyclin balancing impacts contrasted with aspirin, showing it may be beneficial to patients inclined to vascular thrombosis, and in need of anti-arthritis therapy.
ANTI-INFLAMMATORY DRUGS
A 2004 research published in…
